IRIS
COPPOLA, Nicola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.623
EU - Europa 7.405
AS - Asia 641
SA - Sud America 19
AF - Africa 11
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 2
Totale 15.710
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.602
IE - Irlanda 3.112
UA - Ucraina 954
IT - Italia 880
GB - Regno Unito 813
DE - Germania 683
CN - Cina 403
FI - Finlandia 261
GR - Grecia 248
SE - Svezia 213
TR - Turchia 182
FR - Francia 114
BE - Belgio 43
NL - Olanda 29
PL - Polonia 14
RS - Serbia 13
IN - India 12
CA - Canada 9
EU - Europa 9
IR - Iran 9
HK - Hong Kong 8
MX - Messico 8
SG - Singapore 8
BR - Brasile 7
MK - Macedonia 6
ET - Etiopia 5
BO - Bolivia 4
CZ - Repubblica Ceca 4
DK - Danimarca 4
PK - Pakistan 4
AT - Austria 3
RO - Romania 3
TW - Taiwan 3
AR - Argentina 2
BD - Bangladesh 2
CD - Congo 2
DZ - Algeria 2
ES - Italia 2
HU - Ungheria 2
ID - Indonesia 2
IL - Israele 2
JP - Giappone 2
NZ - Nuova Zelanda 2
PE - Perù 2
RU - Federazione Russa 2
VE - Venezuela 2
AM - Armenia 1
CH - Svizzera 1
CO - Colombia 1
CR - Costa Rica 1
EC - Ecuador 1
EG - Egitto 1
GT - Guatemala 1
MA - Marocco 1
MT - Malta 1
MY - Malesia 1
PA - Panama 1
SA - Arabia Saudita 1
TT - Trinidad e Tobago 1
VN - Vietnam 1
Totale 15.710
Salva come PNG Salva come JPEG
Città #
Dublin 3.110
Jacksonville 1.474
Chandler 1.014
Wilmington 546
Chicago 534
Princeton 410
Falls Church 345
Roxbury 318
Bremen 314
Ann Arbor 221
Medford 212
Cambridge 211
Caserta 196
New York 193
Boardman 145
Woodbridge 111
Beijing 110
San Mateo 99
Ashburn 98
Des Moines 90
Houston 89
Naples 80
Mountain View 50
Jinan 46
Nanjing 44
Napoli 43
Brussels 41
Düsseldorf 37
Washington 36
Auburn Hills 28
Helsinki 26
Milan 26
Marano 24
Shenyang 22
Los Angeles 21
Nanchang 21
Rome 21
Norwalk 20
Amsterdam 17
Kunming 17
Munich 16
Hangzhou 14
Kraków 14
Redwood City 14
Zhengzhou 14
Hebei 13
Dearborn 12
Lappeenranta 12
Venice 12
Aversa 11
Grafing 11
Ariano Irpino 10
Guangzhou 10
Lanzhou 10
Groningen 9
Ningbo 9
Paris 9
Altamura 8
Bari 8
Hefei 8
London 8
Salerno 8
Tianjin 8
Catania 7
Jiaxing 7
Marano Di Napoli 7
Seattle 7
Zanjan 7
Changsha 6
Haikou 6
Boydton 5
Fairfield 5
Guadalajara 5
Hong Kong 5
Leawood 5
Nocera Inferiore 5
San Lazzaro di Savena 5
Sant'anastasia 5
Sennori 5
Taizhou 5
Bagheria 4
Belgrade 4
Cercola 4
Como 4
Hanover 4
La Paz 4
Limbiate 4
Marco 4
Portici 4
Pune 4
San Nicola la Strada 4
Shanghai 4
Taiyuan 4
Torre Del Greco 4
Afragola 3
Arzano 3
Bacoli 3
Catanzaro 3
Frankfurt am Main 3
Frattamaggiore 3
Totale 10.879
Salva come PNG Salva come JPEG
Nome #
The role of bacterial colonization of the suture thread in early identification and targeted antibiotic treatment of surgical site infections: A prospective cohort study 1.309
Cannabinoid receptor 2-63 QQ varianti s associated with severe necroinflammation in chronic epatiti C 106
Diagnosis and clinical impact of occult hepatitis B infection in patients with biopsy proven hepatitis C: a multicenter study 102
Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration 89
Real-life glecaprevir/pibrentasvir in a large cohort of patients with hepatitis C virus infection: The MISTRAL study 85
Micro-RNAs in hepatitis B virus-related chronic liver diseases and hepatocellular carcinoma 83
Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infection in undocumented migrants and refugees in southern Italy, January 2012 to June 2013 80
Prevalence and associated risk factors of latent tuberculosis infection among undergraduate and postgraduate dental students: A retrospective study 80
Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C 77
Association Between a Polymorphism in Cannabinoid Receptor 2 and Severe Necroinflammation in Patients With Chronic Hepatitis C. 75
Functional interplay between hepatitis B virus X protein and human miR-125a in HBV infection 75
Vaccination against hepatitis b virus: Are Italian medical students sufficiently protected after the public vaccination programme? 74
An attempt to improve classification of HCV-correlated chronic hepatitis 73
Liver microRNA hsa-miR-125a-5p in HBV Chronic Infection: Correlation with HBV Replication and Disease Progression 73
PREVALENCE OF LATENT TUBERCULOSIS INFECTION IN HEALTHCARE WORKERS AT A HOSPITAL IN NAPLES, ITALY, A LOW-INCIDENCE COUNTRY 73
null 71
Abacavir hypersensivity reaction (HSR), associated to baseline false negative HLAB5701 screening, in antiretroviral treatment naive HIV-1 patient. 70
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 68
Prevalence of latent tuberculosis infection and associated risk factors among 3,374 healthcare students in Italy 67
Acute hepatitis with severe cholestasis and prolonged clinical course due to hepatitis A virus Ia and Ib coinfection 66
The impact of the CB2-63 polymorphism on the histological presentation of chronic hepatitis B. 66
The aetiology of chronic hepatitis in Italy: results from a multicentre national study 66
Patologie virali tropicali (Flavivirus, Filovirus, Arenavirus, Bunyavirus, Togavirus: Chikungunya, 66
The reactivation of occult HBV infection emerging with the case of acute hepatitis B in the wife of a subject treated with rituximab-based chemotherapy 65
PNPLA3 l148M variant as a risk factor for carotid atherosclerosis in chronic epatiti C 63
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens. 61
Does poor glycaemic control affect the immunogenicity of the COVID-19 vaccination in patients with type 2 diabetes: The CAVEAT study 61
The TM6SF2 E167K variant in HIV/HCV coinfection predicts severe liver fibrosis and, only for patients with HCV genotype non 3 severe steatosis. 60
Impact of comorbidities on the severity of chronic hepatitis B at presentation 59
964 HBV occult infection in patients with chronic hepatitis C: a multicentric prospective study 59
Erratum: Vaccination against hepatitis b virus: Are Italian medical students sufficiently protected after the public vaccination programme (Journal of Occupational Medicine and Toxicology (2015) 10:41) 59
Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection 58
Recommendations for the management of acute hepatitis B: position paper of the italian Society for the study of infectious and tropical diseases 57
Does HIV infection favor the sexual transmission of hepatitis C? 57
Cannabinoid Receptor 2 (CB2) Q63 variant in chronic hepatitis C: an association with a more severe hepatocellular necrosis. 57
Patatin-Like Phospholipase Domain-Containing 3 I148M Variant Is Associated with Liver Steatosis and Fat Distribution in Chronic Hepatitis B 57
Characteristics of liver cirrhosis in Italy: Evidence for a decreasing role of HCV aetiology. 57
Peg-interferon plus ribavirin with or without boceprevir or telaprevir for HCV genotype 1: a meta-analysis on the role of response predictors 56
Suture thread check test for detection of surgical site contamination: a prospective study 56
Absence of Helicobacter spp in the liver of patients with primary or metastatic liver cancer 55
416 molecular analysis of genetic variability and epitope stability in a type 1B recurrent HCV infection 55
Cannabinoid receptor 2 (CB2) Q63 variant is associated with a severe histological activity index in patients with chronic hepatitis C 55
Different serological, molecular and cytokine profiles characterize active and inactive disease in patients with chronic hepatitis B virus (HBV) infection 55
Cannabinoid receptor 2-63 RR variant is independently associated with severe necroinflammation in HIV/HCV coinfected patients. 55
A case report of a severe fluoropyrimidine-related toxicity due to an uncommon DPYD variant 55
Daclatasvir: The First of a New Class of Drugs Targeted Against Hepatitis C Virus NS5A 54
The importance of HCV on the burden of chronic liver disease in Italy: a multicenter prevalence study of 9,997 cases 54
P.216 Molecular analysis of genetic variability and epitope stability in a type 1b recurrent HCV infection 54
Impact of PNPLA3 variants on liver histology of 168 patients with HIV infection and chronic hepatitis C. 54
CB2-63 polymorphism and immune-mediated diseases associated with HCV chronic infection. 54
579 CHANGING PATTERN OF HBV GENOTYPES IN ITALY 53
Anti-hepatitis C virus treatment may prevent the progression of liver fibrosis in non-responder human immunodeficiency virus/hepatitis C virus coinfected patients 52
Acute liver failure: a rare clinical presentation of visceral leishmaniasi 52
Diagnosis of hepatitis C virus related acute hepatitis by serial determination of IgM anti-HCV titres. 52
Diagnosis of HCV related acute hepatitis by serial determination of IgM to HCV: a preliminary observation 52
Abstracts of the 63rd Annual Meeting of the American Association for the Study of Liver Diseases. November 9-13, 2012. Boston, Massachusetts, USA. 52
733 REACTIVATION OF OVERT AND OCCULT HBV INFECTION IN IMMUNOSUPPRESSIVE SETTINGS Journal of Hepatology 52
Polimorfismo di IL28B nei soggetti con infezione cronica da HCV con transaminasi persistentemente normali e nei pazienti con epatite cronica d HCV 52
Insulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progression. 51
Anti-HBc positività was associated with histological cirrhosis in patients with chronic hepatitis C 51
4. Infezioni da Salmonelle non-tifoidee: nuovi aspetti epidemiologici 51
Hepatitis C virus superinfection in hepatitis B virus chronic carriers: A reciprocal viral interaction and a variable clinical course 51
HBV transmission from an occult carrier with five mutations in the major hydrophilic region of HBsAg to an immunosuppressed plasma recipient 51
Association between anti-HBc positivity and hepatocellular carcinoma in HBsAg-negative subjects with chronic liver disease: A meta-analysis 51
Epidemiology of HCV and HBV in a High Endemic Area of Southern Italy: Opportunities from the COVID-19 Pandemic—Standardized National Screening or One Tailored to Local Epidemiology? 50
Infezione da HBV in soggetti immigrati: risultati preliminari di uno studio prospettico multicentrico 50
Helicobacter spp. and liver diseases. 50
Acute hepatitis C: clinical and laboratory diagnosis, course of the disease, treatment 49
Acute hepatitis B and C virus coinfection: a virological and clinical study of 3 cases 49
Absence of occult HCV infection in HIV-positive patients 49
Can HCV affect the efficacy of anti-HIV treatment? 49
Treatment of chronic HBV infection in developing countries. 49
Lowered expression of microRNA-125a-5p in human hepatocellular carcinoma and up-regulation of its oncogenic targets sirtuin-7, matrix metalloproteinase-11, and c-Raf 49
Distribution pattern of hepatitis C Virus genotypes and correlation with viral load and risk factors in chronic positive patients 48
Is the liver biopsy necessary for hepatitis C virus carriers with persistently normal aminotransferase levels? 48
The impact of viral molecular diversity on the clinical presentation and outcome of acute hepatitis B in Italy. 48
Clinical and virological characteristics associated with severe acute hepatitis B 48
Tm6sf2 e167k variant is associated with severe steatosis in chronic hepatitis c, regardless of pnapl3 polymorphism 48
[639] ANTIVIRAL TREATMENT IN CHRONIC HBV/HCV COINFECTION: VIROLOGICAL CHANGES IN THREE COMPARTMENTS (PLASMA, PBMC AND LIVER TISSUE) AND CLINICAL OUTCOME 48
Clinical significance of hepatitis B surface antigen mutants 48
Risk factors for carotid atherosclerosis in chronic hepatitis C: no role of the APOC3 variant 48
Liver biopsy in chronic hepatitis C: the experience of 15 Italian wards of infectious diseases. 47
540 IDENTIFICATION OF LAMIVUDINE RESISTANT HBV STRAIN RT204V/I IN ACUTE HEPATITIS B IN ITALY 47
Impact of telaprevir in HCV patients with cirrhosis and RVR: real-life data from Boceprevir or Telaprevir based "triple therapy" experience in southern Italy 47
The TM6SFZ 8167K variant is an independent predictor of severe liver steatosis in chronic hepatitis C 47
Olfactory loss and brain connectivity after COVID-19 47
Liver Histology in Patients With HBsAg Negative Anti-HBc and Anti-HCV Positive Chronic Hepatitis 46
Virological patterns of HCV patients with failure to interferon-free regimens. 46
No effect of MTP polymorphisms on PNPLA3 in HCV-correlated steatosis 46
Eighteen-month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy 46
HAV replication in acute hepatitis with typical and atypical clinical course 45
Role of genetic polymorphisms in hepatitis C virus chronic infection 45
Asunaprevir, a protease inhibitor for the treatment of HCV infection 44
RITUXIMAB-BASED TREATMENT, HCV REPLICATION AND HEPATIC FLARES 44
Anti-HCV IgG avidity index in acute hepatitis C. 44
The long-term immunogenicity of recombinant hepatitis B virus (HBV) vaccine: Contribution of universal HBV vaccination in Italy 44
Hepatitis B virus infection in undocumented immigrants and refugees in Southern Italy: demographic, virological, and clinical features 44
EFFICACY OF CEFTAZIDIME-AVIBACTAM IN MONOTHERAPY OR COMBINATION THERAPY AGAINST CARBAPENEM RESISTANT GRAM NEGATIVE ORGANISMS: A META-ANALYSIS 44
Reply : Absence of Helicobacter species in the liver of patients with primary or metastatic liver cancer 43
Lipodystrophy and serum lipid abnormalities in HIV-positive sub-Saharan population on ART 43
Totale 6.946
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.285
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.285
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201942 0 0 0 0 0 0 0 0 0 0 17 25
2019/20201.698 338 289 35 28 260 72 338 99 121 50 58 10
2020/20212.198 173 18 234 87 377 59 333 270 48 266 291 42
2021/20223.223 179 157 255 126 808 61 155 63 100 242 228 849
2022/20235.606 548 179 373 305 632 325 10 249 2.760 34 101 90
2023/20241.791 180 82 132 177 822 244 31 63 27 33 0 0
Totale 16.500